Special Investigation Of Azithromycin IV For Legionnaires' Disease (Regulatory Post Marketing Commitment Plan) (RESCUE-L)

Pfizer

Status: Completed

Conditions: Legionella Pneumophila Infections; Legionnaires' Disease

Treatments: Drug: Azithromycin IV

Study type: Observational

Funder types: Industry

Identifiers

NCT01784770

A0661208

Details and patient eligibility

About

To collect retrospectively the efficacy and safety information of azithromycin IV on patients with Legionnaires' disease related to their appropriate use in daily practice.

Enrollment: 21 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients who are prescribed Azithromycin (Zithromac) IV for Legionnaires' disease.

Exclusion criteria

• Patients who have been prescribed Zithromac or Zithromac SR.

Trial design

21 participants in 1 patient group

Azithromycin IV

Description:

Subjects who are treated with Azithromycin IV for Legionnaires' disease

Treatment:

Drug: Azithromycin IV